SARS CoV 2 News and Research

RSS

Forecasting epidemiological parameters for the COVID-19 outbreak in the UK

Researchers used the Warwick COVID-19 model, calibrated it to the available public health data streams, and estimated epidemiological quantities such as the effective reproduction number (R) during the first wave of COVID-19 cases in the UK between March–June 2020.

19 Jan 2022

Study reports of receptor-binding domain multimer capable of enhancing the immune response against SARS-CoV-2

Researchers have discovered a new way to induce immunity against the RBD.

19 Jan 2022

Implications of higher viral load in new SARS-CoV-2 variants on airborne transmission

Researchers have examined the implications of the increased airborne transmission from new variants.

19 Jan 2022

Impact of atrial fibrillation in COVID-19 vaccine-induced pericarditis patients

In a new study, a team of researchers described the case of a healthy 49-year old male patient with new-onset atrial fibrillation after receiving the second dose of the COVID-19 mRNA-1273 (Moderna) vaccine.

19 Jan 2022

Impact of COVID-19 on male and female reproductive health

A new review article investigated the relation between SARS-CoV-2 infection and reproductive health.

19 Jan 2022

The latest advancements in polymer-based nanotechnology approaches used to fight against SARS-CoV-2

A recent review discusses the engineering versatility of polymeric nanoparticles - making a good therapeutic alternative against coronavirus diseases.

19 Jan 2022

Scientists assess ACE2 binding and antigenicity of Mu (B.1.621) and A.2.5 spikes

To gain a better understanding of the antigenic properties of Mu and A.2.5 Spikes, Canadian scientists evaluated their capacity to interact with ACE2 and performed binding and neutralization assays with plasma from vaccinated individuals.

18 Jan 2022

Macrodomains represent a unique target for pathogens with pandemic potential

In a new study published in the journal Pathogens, researchers have summarized the role of the macrodomain in viral replication and virulence and further reviewed the development of macrodomain inhibitors as antiviral agents.

18 Jan 2022

Improved SARS-CoV-2 surveillance testing with self-collected saliva

The findings from a recent study conducted in the United States suggest that combining saliva with a practical pooling protocol may open the door for easier surveillance testing for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), particularly in resource-limited settings.

18 Jan 2022

Study provides insights into how SARS-CoV-2 impacts the brain

Some patients who develop new cognitive symptoms after a mild bout of COVID have abnormalities in their cerebrospinal fluid similar to those found in people with other infectious diseases.

18 Jan 2022

Three doses Of Pfizer-BioNTech vaccine could offer sufficient level of protection from Omicron

A new study that evaluated the effectiveness of the BNT162b2 (Pfizer-BioNTech) vaccine against the Omicron variant indicates that three doses could offer a sufficient level of protection from disease caused by the Omicron variant.

18 Jan 2022

Hospital room surfaces unlikely to be a source of SARS-CoV-2 transmission

Hospital rooms where COVID patients were treated had little to no active virus contaminations on surfaces, according to a study at Duke University Hospital that adds to the body of research on how the pandemic respiratory virus is spread.

18 Jan 2022

COVID-19 during pregnancy may induce fetal immune response even in the absence of placental infection

SARS-CoV-2 infection during pregnancy may cause inflammatory immune responses in the fetus, even if the virus does not infect the placenta, according to a small National Institutes of Health study.

18 Jan 2022

Study finds COVID booster maintains strong T cell response against Omicron

New study results posted to the medRxiv* preprint server found that COVID vaccine boosters increase immunity by enhancing T cell immune memory. In the face of the severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) Omicron variant, vaccinated people who had received a third booster shot maintained high T cell responses than people with naturally acquired immunity or vaccine-induced immunity from two doses of the SARS‑CoV‑2 vaccine.

18 Jan 2022

New perspective on SARS-CoV-2 breakthrough infections and booster shot restoration of vaccine efficacy

A recent article published in the journal Science explains how SARS-CoV-2 variants can bypass vaccine-induced immune defenses. However, immunity is restorable with a booster shot. The paper's authors outlined the importance of a booster shot in maintaining immunity and preventing severe infection.

18 Jan 2022

Respiratory viruses lacking NS2 protein can be destroyed by the body's immune response

One viral protein could provide information to deter pneumonia causing the body's exaggerated inflammatory response to respiratory viruses, including the virus that causes COVID-19.

18 Jan 2022

Wastewater-based epidemiology to predict emerging new SARS-CoV-2 variants

In a new study, researchers established a strong approach for deducing public health-relevant epidemiological metrics like relative variant abundance and variant-specific reproduction numbers from wastewater (WW)-derived deep sequenced SARS-CoV-2 genomes.

18 Jan 2022

SARS CoV 2 News and Research

Forecasting epidemiological parameters for the COVID-19 outbreak in the UK

Study reports of receptor-binding domain multimer capable of enhancing the immune response against SARS-CoV-2

Implications of higher viral load in new SARS-CoV-2 variants on airborne transmission

Impact of atrial fibrillation in COVID-19 vaccine-induced pericarditis patients

Impact of COVID-19 on male and female reproductive health

The latest advancements in polymer-based nanotechnology approaches used to fight against SARS-CoV-2

Scientists assess ACE2 binding and antigenicity of Mu (B.1.621) and A.2.5 spikes

Macrodomains represent a unique target for pathogens with pandemic potential

Improved SARS-CoV-2 surveillance testing with self-collected saliva

Study provides insights into how SARS-CoV-2 impacts the brain

Three doses Of Pfizer-BioNTech vaccine could offer sufficient level of protection from Omicron

Hospital room surfaces unlikely to be a source of SARS-CoV-2 transmission

COVID-19 during pregnancy may induce fetal immune response even in the absence of placental infection

Study finds COVID booster maintains strong T cell response against Omicron

New perspective on SARS-CoV-2 breakthrough infections and booster shot restoration of vaccine efficacy

Respiratory viruses lacking NS2 protein can be destroyed by the body's immune response

Wastewater-based epidemiology to predict emerging new SARS-CoV-2 variants

Analyzing disease severity of SARS-CoV-2 Omicron variant using RNA dependent RNA polymerase target delay

Exploring the viral dynamics of SARS-CoV-2 Omicron variant

Dynamics of outbreaks of SARS-CoV-2 variants of concern

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News